Cargando…
Clinical Model for the Prediction of Severe Liver Fibrosis in Adult Patients with Type II Diabetes Mellitus
Background and Objectives: Non-alcoholic fatty liver disease (NAFLD)-related severe liver fibrosis is associated with a higher risk of progressing to decompensated cirrhosis and hepatic failure and developing NAFLD-related hepatocellular carcinoma (HCC), particularly in populations with diabetes. Ou...
Autores principales: | Calapod, Ovidiu Paul, Marin, Andreea Maria, Pantea Stoian, Anca, Fierbinteanu-Braticevici, Carmen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406388/ https://www.ncbi.nlm.nih.gov/pubmed/36010180 http://dx.doi.org/10.3390/diagnostics12081829 |
Ejemplares similares
-
The Impact of Increased Fib-4 Score in Patients with Type II Diabetes Mellitus on COVID-19 Disease Prognosis
por: Calapod, Ovidiu P., et al.
Publicado: (2021) -
The Effects of Cardioprotective Antidiabetic Therapy on Microbiota in Patients with Type 2 Diabetes Mellitus—A Systematic Review
por: Bica, Ioana-Cristina, et al.
Publicado: (2023) -
Role of (13)C methacetin breath test for non invasive staging of liver fibrosis in patients with chronic hepatitis C
por: Fierbinteanu-Braticevici, Carmen, et al.
Publicado: (2014) -
Non – biopsy methods to determine hepatic fibrosis
por: Fierbinteanu–Braticevici, C, et al.
Publicado: (2009) -
The Role of Noninvasive (13)C-Octanoate Breath Test in Assessing the Diagnosis of Nonalcoholic Steatohepatitis
por: Fierbinteanu-Braticevici, Carmen, et al.
Publicado: (2022)